Global S-Amlodipine Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
The global S-Amlodipine market size is projected to grow from US$ 34830 million in 2022 to US$ 75660 million in 2029; it is expected to grow at a CAGR of 11.7% from 2023 to 2029.
Hypertension is a common cardiovascular disease affecting a large proportion of the global population. The increasing prevalence of hypertension worldwide is driving the demand for effective antihypertensive drugs such as S-amlodipine.
S AMLODIPINE belongs to a class of medicines called calcium channel blockers which are primarily taken to treat hypertension (high blood pressure) and angina (chest pain).
LPI (LP Information)' newest research report, the “S-Amlodipine Industry Forecast” looks at past sales and reviews total world S-Amlodipine sales in 2022, providing a comprehensive analysis by region and market sector of projected S-Amlodipine sales for 2023 through 2029. With S-Amlodipine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world S-Amlodipine industry.
This Insight Report provides a comprehensive analysis of the global S-Amlodipine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on S-Amlodipine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global S-Amlodipine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for S-Amlodipine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global S-Amlodipine.
This report presents a comprehensive overview, market shares, and growth opportunities of S-Amlodipine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global S-Amlodipine market?
What factors are driving S-Amlodipine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do S-Amlodipine market opportunities vary by end market size?
How does S-Amlodipine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
The global S-Amlodipine market size is projected to grow from US$ 34830 million in 2022 to US$ 75660 million in 2029; it is expected to grow at a CAGR of 11.7% from 2023 to 2029.
Hypertension is a common cardiovascular disease affecting a large proportion of the global population. The increasing prevalence of hypertension worldwide is driving the demand for effective antihypertensive drugs such as S-amlodipine.
S AMLODIPINE belongs to a class of medicines called calcium channel blockers which are primarily taken to treat hypertension (high blood pressure) and angina (chest pain).
LPI (LP Information)' newest research report, the “S-Amlodipine Industry Forecast” looks at past sales and reviews total world S-Amlodipine sales in 2022, providing a comprehensive analysis by region and market sector of projected S-Amlodipine sales for 2023 through 2029. With S-Amlodipine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world S-Amlodipine industry.
This Insight Report provides a comprehensive analysis of the global S-Amlodipine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on S-Amlodipine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global S-Amlodipine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for S-Amlodipine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global S-Amlodipine.
This report presents a comprehensive overview, market shares, and growth opportunities of S-Amlodipine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Amlodipine Besylate Tablets
- Amlodipine Mesylate Tablets
- Amlodipine Maleate Tablets
- Hypertension
- Angina pectoris
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Aristo Pharmaceuticals Pvt Ltd
- Novartis
- Pfizer
- Lek
- TEVA
- Macleods Pharmaceuticals
- Caraco Pharmaceutical
- Sanis Health
- Jamp Pharma
- Accel Pharma
- Jubilant Generics
- Angita Pharma
- Florida DOH Central Pharmacy
- Chengdu Di'ao Pharmaceutical Group Co., Ltd.
- Yangzijiang Pharmaceutical
What is the 10-year outlook for the global S-Amlodipine market?
What factors are driving S-Amlodipine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do S-Amlodipine market opportunities vary by end market size?
How does S-Amlodipine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global S-Amlodipine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for S-Amlodipine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for S-Amlodipine by Country/Region, 2018, 2022 & 2029
2.2 S-Amlodipine Segment by Type
2.2.1 Amlodipine Besylate Tablets
2.2.2 Amlodipine Mesylate Tablets
2.2.3 Amlodipine Maleate Tablets
2.3 S-Amlodipine Sales by Type
2.3.1 Global S-Amlodipine Sales Market Share by Type (2018-2023)
2.3.2 Global S-Amlodipine Revenue and Market Share by Type (2018-2023)
2.3.3 Global S-Amlodipine Sale Price by Type (2018-2023)
2.4 S-Amlodipine Segment by Application
2.4.1 Hypertension
2.4.2 Angina pectoris
2.5 S-Amlodipine Sales by Application
2.5.1 Global S-Amlodipine Sale Market Share by Application (2018-2023)
2.5.2 Global S-Amlodipine Revenue and Market Share by Application (2018-2023)
2.5.3 Global S-Amlodipine Sale Price by Application (2018-2023)
3 GLOBAL S-AMLODIPINE BY COMPANY
3.1 Global S-Amlodipine Breakdown Data by Company
3.1.1 Global S-Amlodipine Annual Sales by Company (2018-2023)
3.1.2 Global S-Amlodipine Sales Market Share by Company (2018-2023)
3.2 Global S-Amlodipine Annual Revenue by Company (2018-2023)
3.2.1 Global S-Amlodipine Revenue by Company (2018-2023)
3.2.2 Global S-Amlodipine Revenue Market Share by Company (2018-2023)
3.3 Global S-Amlodipine Sale Price by Company
3.4 Key Manufacturers S-Amlodipine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers S-Amlodipine Product Location Distribution
3.4.2 Players S-Amlodipine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR S-AMLODIPINE BY GEOGRAPHIC REGION
4.1 World Historic S-Amlodipine Market Size by Geographic Region (2018-2023)
4.1.1 Global S-Amlodipine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global S-Amlodipine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic S-Amlodipine Market Size by Country/Region (2018-2023)
4.2.1 Global S-Amlodipine Annual Sales by Country/Region (2018-2023)
4.2.2 Global S-Amlodipine Annual Revenue by Country/Region (2018-2023)
4.3 Americas S-Amlodipine Sales Growth
4.4 APAC S-Amlodipine Sales Growth
4.5 Europe S-Amlodipine Sales Growth
4.6 Middle East & Africa S-Amlodipine Sales Growth
5 AMERICAS
5.1 Americas S-Amlodipine Sales by Country
5.1.1 Americas S-Amlodipine Sales by Country (2018-2023)
5.1.2 Americas S-Amlodipine Revenue by Country (2018-2023)
5.2 Americas S-Amlodipine Sales by Type
5.3 Americas S-Amlodipine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC S-Amlodipine Sales by Region
6.1.1 APAC S-Amlodipine Sales by Region (2018-2023)
6.1.2 APAC S-Amlodipine Revenue by Region (2018-2023)
6.2 APAC S-Amlodipine Sales by Type
6.3 APAC S-Amlodipine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe S-Amlodipine by Country
7.1.1 Europe S-Amlodipine Sales by Country (2018-2023)
7.1.2 Europe S-Amlodipine Revenue by Country (2018-2023)
7.2 Europe S-Amlodipine Sales by Type
7.3 Europe S-Amlodipine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa S-Amlodipine by Country
8.1.1 Middle East & Africa S-Amlodipine Sales by Country (2018-2023)
8.1.2 Middle East & Africa S-Amlodipine Revenue by Country (2018-2023)
8.2 Middle East & Africa S-Amlodipine Sales by Type
8.3 Middle East & Africa S-Amlodipine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of S-Amlodipine
10.3 Manufacturing Process Analysis of S-Amlodipine
10.4 Industry Chain Structure of S-Amlodipine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 S-Amlodipine Distributors
11.3 S-Amlodipine Customer
12 WORLD FORECAST REVIEW FOR S-AMLODIPINE BY GEOGRAPHIC REGION
12.1 Global S-Amlodipine Market Size Forecast by Region
12.1.1 Global S-Amlodipine Forecast by Region (2024-2029)
12.1.2 Global S-Amlodipine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global S-Amlodipine Forecast by Type
12.7 Global S-Amlodipine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Aristo Pharmaceuticals Pvt Ltd
13.1.1 Aristo Pharmaceuticals Pvt Ltd Company Information
13.1.2 Aristo Pharmaceuticals Pvt Ltd S-Amlodipine Product Portfolios and Specifications
13.1.3 Aristo Pharmaceuticals Pvt Ltd S-Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Aristo Pharmaceuticals Pvt Ltd Main Business Overview
13.1.5 Aristo Pharmaceuticals Pvt Ltd Latest Developments
13.2 Novartis
13.2.1 Novartis Company Information
13.2.2 Novartis S-Amlodipine Product Portfolios and Specifications
13.2.3 Novartis S-Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Novartis Main Business Overview
13.2.5 Novartis Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer S-Amlodipine Product Portfolios and Specifications
13.3.3 Pfizer S-Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 Lek
13.4.1 Lek Company Information
13.4.2 Lek S-Amlodipine Product Portfolios and Specifications
13.4.3 Lek S-Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Lek Main Business Overview
13.4.5 Lek Latest Developments
13.5 TEVA
13.5.1 TEVA Company Information
13.5.2 TEVA S-Amlodipine Product Portfolios and Specifications
13.5.3 TEVA S-Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 TEVA Main Business Overview
13.5.5 TEVA Latest Developments
13.6 Macleods Pharmaceuticals
13.6.1 Macleods Pharmaceuticals Company Information
13.6.2 Macleods Pharmaceuticals S-Amlodipine Product Portfolios and Specifications
13.6.3 Macleods Pharmaceuticals S-Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Macleods Pharmaceuticals Main Business Overview
13.6.5 Macleods Pharmaceuticals Latest Developments
13.7 Caraco Pharmaceutical
13.7.1 Caraco Pharmaceutical Company Information
13.7.2 Caraco Pharmaceutical S-Amlodipine Product Portfolios and Specifications
13.7.3 Caraco Pharmaceutical S-Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Caraco Pharmaceutical Main Business Overview
13.7.5 Caraco Pharmaceutical Latest Developments
13.8 Sanis Health
13.8.1 Sanis Health Company Information
13.8.2 Sanis Health S-Amlodipine Product Portfolios and Specifications
13.8.3 Sanis Health S-Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Sanis Health Main Business Overview
13.8.5 Sanis Health Latest Developments
13.9 Jamp Pharma
13.9.1 Jamp Pharma Company Information
13.9.2 Jamp Pharma S-Amlodipine Product Portfolios and Specifications
13.9.3 Jamp Pharma S-Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Jamp Pharma Main Business Overview
13.9.5 Jamp Pharma Latest Developments
13.10 Accel Pharma
13.10.1 Accel Pharma Company Information
13.10.2 Accel Pharma S-Amlodipine Product Portfolios and Specifications
13.10.3 Accel Pharma S-Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Accel Pharma Main Business Overview
13.10.5 Accel Pharma Latest Developments
13.11 Jubilant Generics
13.11.1 Jubilant Generics Company Information
13.11.2 Jubilant Generics S-Amlodipine Product Portfolios and Specifications
13.11.3 Jubilant Generics S-Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Jubilant Generics Main Business Overview
13.11.5 Jubilant Generics Latest Developments
13.12 Angita Pharma
13.12.1 Angita Pharma Company Information
13.12.2 Angita Pharma S-Amlodipine Product Portfolios and Specifications
13.12.3 Angita Pharma S-Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Angita Pharma Main Business Overview
13.12.5 Angita Pharma Latest Developments
13.13 Florida DOH Central Pharmacy
13.13.1 Florida DOH Central Pharmacy Company Information
13.13.2 Florida DOH Central Pharmacy S-Amlodipine Product Portfolios and Specifications
13.13.3 Florida DOH Central Pharmacy S-Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Florida DOH Central Pharmacy Main Business Overview
13.13.5 Florida DOH Central Pharmacy Latest Developments
13.14 Chengdu Di'ao Pharmaceutical Group Co., Ltd.
13.14.1 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Company Information
13.14.2 Chengdu Di'ao Pharmaceutical Group Co., Ltd. S-Amlodipine Product Portfolios and Specifications
13.14.3 Chengdu Di'ao Pharmaceutical Group Co., Ltd. S-Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Main Business Overview
13.14.5 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Latest Developments
13.15 Yangzijiang Pharmaceutical
13.15.1 Yangzijiang Pharmaceutical Company Information
13.15.2 Yangzijiang Pharmaceutical S-Amlodipine Product Portfolios and Specifications
13.15.3 Yangzijiang Pharmaceutical S-Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Yangzijiang Pharmaceutical Main Business Overview
13.15.5 Yangzijiang Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global S-Amlodipine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for S-Amlodipine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for S-Amlodipine by Country/Region, 2018, 2022 & 2029
2.2 S-Amlodipine Segment by Type
2.2.1 Amlodipine Besylate Tablets
2.2.2 Amlodipine Mesylate Tablets
2.2.3 Amlodipine Maleate Tablets
2.3 S-Amlodipine Sales by Type
2.3.1 Global S-Amlodipine Sales Market Share by Type (2018-2023)
2.3.2 Global S-Amlodipine Revenue and Market Share by Type (2018-2023)
2.3.3 Global S-Amlodipine Sale Price by Type (2018-2023)
2.4 S-Amlodipine Segment by Application
2.4.1 Hypertension
2.4.2 Angina pectoris
2.5 S-Amlodipine Sales by Application
2.5.1 Global S-Amlodipine Sale Market Share by Application (2018-2023)
2.5.2 Global S-Amlodipine Revenue and Market Share by Application (2018-2023)
2.5.3 Global S-Amlodipine Sale Price by Application (2018-2023)
3 GLOBAL S-AMLODIPINE BY COMPANY
3.1 Global S-Amlodipine Breakdown Data by Company
3.1.1 Global S-Amlodipine Annual Sales by Company (2018-2023)
3.1.2 Global S-Amlodipine Sales Market Share by Company (2018-2023)
3.2 Global S-Amlodipine Annual Revenue by Company (2018-2023)
3.2.1 Global S-Amlodipine Revenue by Company (2018-2023)
3.2.2 Global S-Amlodipine Revenue Market Share by Company (2018-2023)
3.3 Global S-Amlodipine Sale Price by Company
3.4 Key Manufacturers S-Amlodipine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers S-Amlodipine Product Location Distribution
3.4.2 Players S-Amlodipine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR S-AMLODIPINE BY GEOGRAPHIC REGION
4.1 World Historic S-Amlodipine Market Size by Geographic Region (2018-2023)
4.1.1 Global S-Amlodipine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global S-Amlodipine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic S-Amlodipine Market Size by Country/Region (2018-2023)
4.2.1 Global S-Amlodipine Annual Sales by Country/Region (2018-2023)
4.2.2 Global S-Amlodipine Annual Revenue by Country/Region (2018-2023)
4.3 Americas S-Amlodipine Sales Growth
4.4 APAC S-Amlodipine Sales Growth
4.5 Europe S-Amlodipine Sales Growth
4.6 Middle East & Africa S-Amlodipine Sales Growth
5 AMERICAS
5.1 Americas S-Amlodipine Sales by Country
5.1.1 Americas S-Amlodipine Sales by Country (2018-2023)
5.1.2 Americas S-Amlodipine Revenue by Country (2018-2023)
5.2 Americas S-Amlodipine Sales by Type
5.3 Americas S-Amlodipine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC S-Amlodipine Sales by Region
6.1.1 APAC S-Amlodipine Sales by Region (2018-2023)
6.1.2 APAC S-Amlodipine Revenue by Region (2018-2023)
6.2 APAC S-Amlodipine Sales by Type
6.3 APAC S-Amlodipine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe S-Amlodipine by Country
7.1.1 Europe S-Amlodipine Sales by Country (2018-2023)
7.1.2 Europe S-Amlodipine Revenue by Country (2018-2023)
7.2 Europe S-Amlodipine Sales by Type
7.3 Europe S-Amlodipine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa S-Amlodipine by Country
8.1.1 Middle East & Africa S-Amlodipine Sales by Country (2018-2023)
8.1.2 Middle East & Africa S-Amlodipine Revenue by Country (2018-2023)
8.2 Middle East & Africa S-Amlodipine Sales by Type
8.3 Middle East & Africa S-Amlodipine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of S-Amlodipine
10.3 Manufacturing Process Analysis of S-Amlodipine
10.4 Industry Chain Structure of S-Amlodipine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 S-Amlodipine Distributors
11.3 S-Amlodipine Customer
12 WORLD FORECAST REVIEW FOR S-AMLODIPINE BY GEOGRAPHIC REGION
12.1 Global S-Amlodipine Market Size Forecast by Region
12.1.1 Global S-Amlodipine Forecast by Region (2024-2029)
12.1.2 Global S-Amlodipine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global S-Amlodipine Forecast by Type
12.7 Global S-Amlodipine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Aristo Pharmaceuticals Pvt Ltd
13.1.1 Aristo Pharmaceuticals Pvt Ltd Company Information
13.1.2 Aristo Pharmaceuticals Pvt Ltd S-Amlodipine Product Portfolios and Specifications
13.1.3 Aristo Pharmaceuticals Pvt Ltd S-Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Aristo Pharmaceuticals Pvt Ltd Main Business Overview
13.1.5 Aristo Pharmaceuticals Pvt Ltd Latest Developments
13.2 Novartis
13.2.1 Novartis Company Information
13.2.2 Novartis S-Amlodipine Product Portfolios and Specifications
13.2.3 Novartis S-Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Novartis Main Business Overview
13.2.5 Novartis Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer S-Amlodipine Product Portfolios and Specifications
13.3.3 Pfizer S-Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 Lek
13.4.1 Lek Company Information
13.4.2 Lek S-Amlodipine Product Portfolios and Specifications
13.4.3 Lek S-Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Lek Main Business Overview
13.4.5 Lek Latest Developments
13.5 TEVA
13.5.1 TEVA Company Information
13.5.2 TEVA S-Amlodipine Product Portfolios and Specifications
13.5.3 TEVA S-Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 TEVA Main Business Overview
13.5.5 TEVA Latest Developments
13.6 Macleods Pharmaceuticals
13.6.1 Macleods Pharmaceuticals Company Information
13.6.2 Macleods Pharmaceuticals S-Amlodipine Product Portfolios and Specifications
13.6.3 Macleods Pharmaceuticals S-Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Macleods Pharmaceuticals Main Business Overview
13.6.5 Macleods Pharmaceuticals Latest Developments
13.7 Caraco Pharmaceutical
13.7.1 Caraco Pharmaceutical Company Information
13.7.2 Caraco Pharmaceutical S-Amlodipine Product Portfolios and Specifications
13.7.3 Caraco Pharmaceutical S-Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Caraco Pharmaceutical Main Business Overview
13.7.5 Caraco Pharmaceutical Latest Developments
13.8 Sanis Health
13.8.1 Sanis Health Company Information
13.8.2 Sanis Health S-Amlodipine Product Portfolios and Specifications
13.8.3 Sanis Health S-Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Sanis Health Main Business Overview
13.8.5 Sanis Health Latest Developments
13.9 Jamp Pharma
13.9.1 Jamp Pharma Company Information
13.9.2 Jamp Pharma S-Amlodipine Product Portfolios and Specifications
13.9.3 Jamp Pharma S-Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Jamp Pharma Main Business Overview
13.9.5 Jamp Pharma Latest Developments
13.10 Accel Pharma
13.10.1 Accel Pharma Company Information
13.10.2 Accel Pharma S-Amlodipine Product Portfolios and Specifications
13.10.3 Accel Pharma S-Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Accel Pharma Main Business Overview
13.10.5 Accel Pharma Latest Developments
13.11 Jubilant Generics
13.11.1 Jubilant Generics Company Information
13.11.2 Jubilant Generics S-Amlodipine Product Portfolios and Specifications
13.11.3 Jubilant Generics S-Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Jubilant Generics Main Business Overview
13.11.5 Jubilant Generics Latest Developments
13.12 Angita Pharma
13.12.1 Angita Pharma Company Information
13.12.2 Angita Pharma S-Amlodipine Product Portfolios and Specifications
13.12.3 Angita Pharma S-Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Angita Pharma Main Business Overview
13.12.5 Angita Pharma Latest Developments
13.13 Florida DOH Central Pharmacy
13.13.1 Florida DOH Central Pharmacy Company Information
13.13.2 Florida DOH Central Pharmacy S-Amlodipine Product Portfolios and Specifications
13.13.3 Florida DOH Central Pharmacy S-Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Florida DOH Central Pharmacy Main Business Overview
13.13.5 Florida DOH Central Pharmacy Latest Developments
13.14 Chengdu Di'ao Pharmaceutical Group Co., Ltd.
13.14.1 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Company Information
13.14.2 Chengdu Di'ao Pharmaceutical Group Co., Ltd. S-Amlodipine Product Portfolios and Specifications
13.14.3 Chengdu Di'ao Pharmaceutical Group Co., Ltd. S-Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Main Business Overview
13.14.5 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Latest Developments
13.15 Yangzijiang Pharmaceutical
13.15.1 Yangzijiang Pharmaceutical Company Information
13.15.2 Yangzijiang Pharmaceutical S-Amlodipine Product Portfolios and Specifications
13.15.3 Yangzijiang Pharmaceutical S-Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Yangzijiang Pharmaceutical Main Business Overview
13.15.5 Yangzijiang Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. S-Amlodipine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. S-Amlodipine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Amlodipine Besylate Tablets
Table 4. Major Players of Amlodipine Mesylate Tablets
Table 5. Major Players of Amlodipine Maleate Tablets
Table 6. Global S-Amlodipine Sales by Type (2018-2023) & (K Units)
Table 7. Global S-Amlodipine Sales Market Share by Type (2018-2023)
Table 8. Global S-Amlodipine Revenue by Type (2018-2023) & ($ million)
Table 9. Global S-Amlodipine Revenue Market Share by Type (2018-2023)
Table 10. Global S-Amlodipine Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global S-Amlodipine Sales by Application (2018-2023) & (K Units)
Table 12. Global S-Amlodipine Sales Market Share by Application (2018-2023)
Table 13. Global S-Amlodipine Revenue by Application (2018-2023)
Table 14. Global S-Amlodipine Revenue Market Share by Application (2018-2023)
Table 15. Global S-Amlodipine Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global S-Amlodipine Sales by Company (2018-2023) & (K Units)
Table 17. Global S-Amlodipine Sales Market Share by Company (2018-2023)
Table 18. Global S-Amlodipine Revenue by Company (2018-2023) ($ Millions)
Table 19. Global S-Amlodipine Revenue Market Share by Company (2018-2023)
Table 20. Global S-Amlodipine Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers S-Amlodipine Producing Area Distribution and Sales Area
Table 22. Players S-Amlodipine Products Offered
Table 23. S-Amlodipine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global S-Amlodipine Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global S-Amlodipine Sales Market Share Geographic Region (2018-2023)
Table 28. Global S-Amlodipine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global S-Amlodipine Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global S-Amlodipine Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global S-Amlodipine Sales Market Share by Country/Region (2018-2023)
Table 32. Global S-Amlodipine Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global S-Amlodipine Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas S-Amlodipine Sales by Country (2018-2023) & (K Units)
Table 35. Americas S-Amlodipine Sales Market Share by Country (2018-2023)
Table 36. Americas S-Amlodipine Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas S-Amlodipine Revenue Market Share by Country (2018-2023)
Table 38. Americas S-Amlodipine Sales by Type (2018-2023) & (K Units)
Table 39. Americas S-Amlodipine Sales by Application (2018-2023) & (K Units)
Table 40. APAC S-Amlodipine Sales by Region (2018-2023) & (K Units)
Table 41. APAC S-Amlodipine Sales Market Share by Region (2018-2023)
Table 42. APAC S-Amlodipine Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC S-Amlodipine Revenue Market Share by Region (2018-2023)
Table 44. APAC S-Amlodipine Sales by Type (2018-2023) & (K Units)
Table 45. APAC S-Amlodipine Sales by Application (2018-2023) & (K Units)
Table 46. Europe S-Amlodipine Sales by Country (2018-2023) & (K Units)
Table 47. Europe S-Amlodipine Sales Market Share by Country (2018-2023)
Table 48. Europe S-Amlodipine Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe S-Amlodipine Revenue Market Share by Country (2018-2023)
Table 50. Europe S-Amlodipine Sales by Type (2018-2023) & (K Units)
Table 51. Europe S-Amlodipine Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa S-Amlodipine Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa S-Amlodipine Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa S-Amlodipine Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa S-Amlodipine Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa S-Amlodipine Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa S-Amlodipine Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of S-Amlodipine
Table 59. Key Market Challenges & Risks of S-Amlodipine
Table 60. Key Industry Trends of S-Amlodipine
Table 61. S-Amlodipine Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. S-Amlodipine Distributors List
Table 64. S-Amlodipine Customer List
Table 65. Global S-Amlodipine Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global S-Amlodipine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas S-Amlodipine Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas S-Amlodipine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC S-Amlodipine Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC S-Amlodipine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe S-Amlodipine Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe S-Amlodipine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa S-Amlodipine Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa S-Amlodipine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global S-Amlodipine Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global S-Amlodipine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global S-Amlodipine Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global S-Amlodipine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Aristo Pharmaceuticals Pvt Ltd Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 80. Aristo Pharmaceuticals Pvt Ltd S-Amlodipine Product Portfolios and Specifications
Table 81. Aristo Pharmaceuticals Pvt Ltd S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Aristo Pharmaceuticals Pvt Ltd Main Business
Table 83. Aristo Pharmaceuticals Pvt Ltd Latest Developments
Table 84. Novartis Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 85. Novartis S-Amlodipine Product Portfolios and Specifications
Table 86. Novartis S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Novartis Main Business
Table 88. Novartis Latest Developments
Table 89. Pfizer Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 90. Pfizer S-Amlodipine Product Portfolios and Specifications
Table 91. Pfizer S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Pfizer Main Business
Table 93. Pfizer Latest Developments
Table 94. Lek Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 95. Lek S-Amlodipine Product Portfolios and Specifications
Table 96. Lek S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Lek Main Business
Table 98. Lek Latest Developments
Table 99. TEVA Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 100. TEVA S-Amlodipine Product Portfolios and Specifications
Table 101. TEVA S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. TEVA Main Business
Table 103. TEVA Latest Developments
Table 104. Macleods Pharmaceuticals Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 105. Macleods Pharmaceuticals S-Amlodipine Product Portfolios and Specifications
Table 106. Macleods Pharmaceuticals S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Macleods Pharmaceuticals Main Business
Table 108. Macleods Pharmaceuticals Latest Developments
Table 109. Caraco Pharmaceutical Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 110. Caraco Pharmaceutical S-Amlodipine Product Portfolios and Specifications
Table 111. Caraco Pharmaceutical S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Caraco Pharmaceutical Main Business
Table 113. Caraco Pharmaceutical Latest Developments
Table 114. Sanis Health Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 115. Sanis Health S-Amlodipine Product Portfolios and Specifications
Table 116. Sanis Health S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Sanis Health Main Business
Table 118. Sanis Health Latest Developments
Table 119. Jamp Pharma Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 120. Jamp Pharma S-Amlodipine Product Portfolios and Specifications
Table 121. Jamp Pharma S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Jamp Pharma Main Business
Table 123. Jamp Pharma Latest Developments
Table 124. Accel Pharma Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 125. Accel Pharma S-Amlodipine Product Portfolios and Specifications
Table 126. Accel Pharma S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Accel Pharma Main Business
Table 128. Accel Pharma Latest Developments
Table 129. Jubilant Generics Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 130. Jubilant Generics S-Amlodipine Product Portfolios and Specifications
Table 131. Jubilant Generics S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. Jubilant Generics Main Business
Table 133. Jubilant Generics Latest Developments
Table 134. Angita Pharma Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 135. Angita Pharma S-Amlodipine Product Portfolios and Specifications
Table 136. Angita Pharma S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 137. Angita Pharma Main Business
Table 138. Angita Pharma Latest Developments
Table 139. Florida DOH Central Pharmacy Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 140. Florida DOH Central Pharmacy S-Amlodipine Product Portfolios and Specifications
Table 141. Florida DOH Central Pharmacy S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 142. Florida DOH Central Pharmacy Main Business
Table 143. Florida DOH Central Pharmacy Latest Developments
Table 144. Chengdu Di'ao Pharmaceutical Group Co., Ltd. Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 145. Chengdu Di'ao Pharmaceutical Group Co., Ltd. S-Amlodipine Product Portfolios and Specifications
Table 146. Chengdu Di'ao Pharmaceutical Group Co., Ltd. S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 147. Chengdu Di'ao Pharmaceutical Group Co., Ltd. Main Business
Table 148. Chengdu Di'ao Pharmaceutical Group Co., Ltd. Latest Developments
Table 149. Yangzijiang Pharmaceutical Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 150. Yangzijiang Pharmaceutical S-Amlodipine Product Portfolios and Specifications
Table 151. Yangzijiang Pharmaceutical S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 152. Yangzijiang Pharmaceutical Main Business
Table 153. Yangzijiang Pharmaceutical Latest Developments
Table 1. S-Amlodipine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. S-Amlodipine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Amlodipine Besylate Tablets
Table 4. Major Players of Amlodipine Mesylate Tablets
Table 5. Major Players of Amlodipine Maleate Tablets
Table 6. Global S-Amlodipine Sales by Type (2018-2023) & (K Units)
Table 7. Global S-Amlodipine Sales Market Share by Type (2018-2023)
Table 8. Global S-Amlodipine Revenue by Type (2018-2023) & ($ million)
Table 9. Global S-Amlodipine Revenue Market Share by Type (2018-2023)
Table 10. Global S-Amlodipine Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global S-Amlodipine Sales by Application (2018-2023) & (K Units)
Table 12. Global S-Amlodipine Sales Market Share by Application (2018-2023)
Table 13. Global S-Amlodipine Revenue by Application (2018-2023)
Table 14. Global S-Amlodipine Revenue Market Share by Application (2018-2023)
Table 15. Global S-Amlodipine Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global S-Amlodipine Sales by Company (2018-2023) & (K Units)
Table 17. Global S-Amlodipine Sales Market Share by Company (2018-2023)
Table 18. Global S-Amlodipine Revenue by Company (2018-2023) ($ Millions)
Table 19. Global S-Amlodipine Revenue Market Share by Company (2018-2023)
Table 20. Global S-Amlodipine Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers S-Amlodipine Producing Area Distribution and Sales Area
Table 22. Players S-Amlodipine Products Offered
Table 23. S-Amlodipine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global S-Amlodipine Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global S-Amlodipine Sales Market Share Geographic Region (2018-2023)
Table 28. Global S-Amlodipine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global S-Amlodipine Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global S-Amlodipine Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global S-Amlodipine Sales Market Share by Country/Region (2018-2023)
Table 32. Global S-Amlodipine Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global S-Amlodipine Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas S-Amlodipine Sales by Country (2018-2023) & (K Units)
Table 35. Americas S-Amlodipine Sales Market Share by Country (2018-2023)
Table 36. Americas S-Amlodipine Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas S-Amlodipine Revenue Market Share by Country (2018-2023)
Table 38. Americas S-Amlodipine Sales by Type (2018-2023) & (K Units)
Table 39. Americas S-Amlodipine Sales by Application (2018-2023) & (K Units)
Table 40. APAC S-Amlodipine Sales by Region (2018-2023) & (K Units)
Table 41. APAC S-Amlodipine Sales Market Share by Region (2018-2023)
Table 42. APAC S-Amlodipine Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC S-Amlodipine Revenue Market Share by Region (2018-2023)
Table 44. APAC S-Amlodipine Sales by Type (2018-2023) & (K Units)
Table 45. APAC S-Amlodipine Sales by Application (2018-2023) & (K Units)
Table 46. Europe S-Amlodipine Sales by Country (2018-2023) & (K Units)
Table 47. Europe S-Amlodipine Sales Market Share by Country (2018-2023)
Table 48. Europe S-Amlodipine Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe S-Amlodipine Revenue Market Share by Country (2018-2023)
Table 50. Europe S-Amlodipine Sales by Type (2018-2023) & (K Units)
Table 51. Europe S-Amlodipine Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa S-Amlodipine Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa S-Amlodipine Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa S-Amlodipine Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa S-Amlodipine Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa S-Amlodipine Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa S-Amlodipine Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of S-Amlodipine
Table 59. Key Market Challenges & Risks of S-Amlodipine
Table 60. Key Industry Trends of S-Amlodipine
Table 61. S-Amlodipine Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. S-Amlodipine Distributors List
Table 64. S-Amlodipine Customer List
Table 65. Global S-Amlodipine Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global S-Amlodipine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas S-Amlodipine Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas S-Amlodipine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC S-Amlodipine Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC S-Amlodipine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe S-Amlodipine Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe S-Amlodipine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa S-Amlodipine Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa S-Amlodipine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global S-Amlodipine Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global S-Amlodipine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global S-Amlodipine Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global S-Amlodipine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Aristo Pharmaceuticals Pvt Ltd Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 80. Aristo Pharmaceuticals Pvt Ltd S-Amlodipine Product Portfolios and Specifications
Table 81. Aristo Pharmaceuticals Pvt Ltd S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Aristo Pharmaceuticals Pvt Ltd Main Business
Table 83. Aristo Pharmaceuticals Pvt Ltd Latest Developments
Table 84. Novartis Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 85. Novartis S-Amlodipine Product Portfolios and Specifications
Table 86. Novartis S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Novartis Main Business
Table 88. Novartis Latest Developments
Table 89. Pfizer Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 90. Pfizer S-Amlodipine Product Portfolios and Specifications
Table 91. Pfizer S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Pfizer Main Business
Table 93. Pfizer Latest Developments
Table 94. Lek Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 95. Lek S-Amlodipine Product Portfolios and Specifications
Table 96. Lek S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Lek Main Business
Table 98. Lek Latest Developments
Table 99. TEVA Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 100. TEVA S-Amlodipine Product Portfolios and Specifications
Table 101. TEVA S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. TEVA Main Business
Table 103. TEVA Latest Developments
Table 104. Macleods Pharmaceuticals Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 105. Macleods Pharmaceuticals S-Amlodipine Product Portfolios and Specifications
Table 106. Macleods Pharmaceuticals S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Macleods Pharmaceuticals Main Business
Table 108. Macleods Pharmaceuticals Latest Developments
Table 109. Caraco Pharmaceutical Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 110. Caraco Pharmaceutical S-Amlodipine Product Portfolios and Specifications
Table 111. Caraco Pharmaceutical S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Caraco Pharmaceutical Main Business
Table 113. Caraco Pharmaceutical Latest Developments
Table 114. Sanis Health Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 115. Sanis Health S-Amlodipine Product Portfolios and Specifications
Table 116. Sanis Health S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Sanis Health Main Business
Table 118. Sanis Health Latest Developments
Table 119. Jamp Pharma Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 120. Jamp Pharma S-Amlodipine Product Portfolios and Specifications
Table 121. Jamp Pharma S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Jamp Pharma Main Business
Table 123. Jamp Pharma Latest Developments
Table 124. Accel Pharma Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 125. Accel Pharma S-Amlodipine Product Portfolios and Specifications
Table 126. Accel Pharma S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Accel Pharma Main Business
Table 128. Accel Pharma Latest Developments
Table 129. Jubilant Generics Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 130. Jubilant Generics S-Amlodipine Product Portfolios and Specifications
Table 131. Jubilant Generics S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. Jubilant Generics Main Business
Table 133. Jubilant Generics Latest Developments
Table 134. Angita Pharma Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 135. Angita Pharma S-Amlodipine Product Portfolios and Specifications
Table 136. Angita Pharma S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 137. Angita Pharma Main Business
Table 138. Angita Pharma Latest Developments
Table 139. Florida DOH Central Pharmacy Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 140. Florida DOH Central Pharmacy S-Amlodipine Product Portfolios and Specifications
Table 141. Florida DOH Central Pharmacy S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 142. Florida DOH Central Pharmacy Main Business
Table 143. Florida DOH Central Pharmacy Latest Developments
Table 144. Chengdu Di'ao Pharmaceutical Group Co., Ltd. Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 145. Chengdu Di'ao Pharmaceutical Group Co., Ltd. S-Amlodipine Product Portfolios and Specifications
Table 146. Chengdu Di'ao Pharmaceutical Group Co., Ltd. S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 147. Chengdu Di'ao Pharmaceutical Group Co., Ltd. Main Business
Table 148. Chengdu Di'ao Pharmaceutical Group Co., Ltd. Latest Developments
Table 149. Yangzijiang Pharmaceutical Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 150. Yangzijiang Pharmaceutical S-Amlodipine Product Portfolios and Specifications
Table 151. Yangzijiang Pharmaceutical S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 152. Yangzijiang Pharmaceutical Main Business
Table 153. Yangzijiang Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of S-Amlodipine
Figure 2. S-Amlodipine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global S-Amlodipine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global S-Amlodipine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. S-Amlodipine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Amlodipine Besylate Tablets
Figure 10. Product Picture of Amlodipine Mesylate Tablets
Figure 11. Product Picture of Amlodipine Maleate Tablets
Figure 12. Global S-Amlodipine Sales Market Share by Type in 2022
Figure 13. Global S-Amlodipine Revenue Market Share by Type (2018-2023)
Figure 14. S-Amlodipine Consumed in Hypertension
Figure 15. Global S-Amlodipine Market: Hypertension (2018-2023) & (K Units)
Figure 16. S-Amlodipine Consumed in Angina pectoris
Figure 17. Global S-Amlodipine Market: Angina pectoris (2018-2023) & (K Units)
Figure 18. Global S-Amlodipine Sales Market Share by Application (2022)
Figure 19. Global S-Amlodipine Revenue Market Share by Application in 2022
Figure 20. S-Amlodipine Sales Market by Company in 2022 (K Units)
Figure 21. Global S-Amlodipine Sales Market Share by Company in 2022
Figure 22. S-Amlodipine Revenue Market by Company in 2022 ($ Million)
Figure 23. Global S-Amlodipine Revenue Market Share by Company in 2022
Figure 24. Global S-Amlodipine Sales Market Share by Geographic Region (2018-2023)
Figure 25. Global S-Amlodipine Revenue Market Share by Geographic Region in 2022
Figure 26. Americas S-Amlodipine Sales 2018-2023 (K Units)
Figure 27. Americas S-Amlodipine Revenue 2018-2023 ($ Millions)
Figure 28. APAC S-Amlodipine Sales 2018-2023 (K Units)
Figure 29. APAC S-Amlodipine Revenue 2018-2023 ($ Millions)
Figure 30. Europe S-Amlodipine Sales 2018-2023 (K Units)
Figure 31. Europe S-Amlodipine Revenue 2018-2023 ($ Millions)
Figure 32. Middle East & Africa S-Amlodipine Sales 2018-2023 (K Units)
Figure 33. Middle East & Africa S-Amlodipine Revenue 2018-2023 ($ Millions)
Figure 34. Americas S-Amlodipine Sales Market Share by Country in 2022
Figure 35. Americas S-Amlodipine Revenue Market Share by Country in 2022
Figure 36. Americas S-Amlodipine Sales Market Share by Type (2018-2023)
Figure 37. Americas S-Amlodipine Sales Market Share by Application (2018-2023)
Figure 38. United States S-Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 39. Canada S-Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Mexico S-Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 41. Brazil S-Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 42. APAC S-Amlodipine Sales Market Share by Region in 2022
Figure 43. APAC S-Amlodipine Revenue Market Share by Regions in 2022
Figure 44. APAC S-Amlodipine Sales Market Share by Type (2018-2023)
Figure 45. APAC S-Amlodipine Sales Market Share by Application (2018-2023)
Figure 46. China S-Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 47. Japan S-Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 48. South Korea S-Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 49. Southeast Asia S-Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 50. India S-Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 51. Australia S-Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 52. China Taiwan S-Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 53. Europe S-Amlodipine Sales Market Share by Country in 2022
Figure 54. Europe S-Amlodipine Revenue Market Share by Country in 2022
Figure 55. Europe S-Amlodipine Sales Market Share by Type (2018-2023)
Figure 56. Europe S-Amlodipine Sales Market Share by Application (2018-2023)
Figure 57. Germany S-Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 58. France S-Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 59. UK S-Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 60. Italy S-Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Russia S-Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 62. Middle East & Africa S-Amlodipine Sales Market Share by Country in 2022
Figure 63. Middle East & Africa S-Amlodipine Revenue Market Share by Country in 2022
Figure 64. Middle East & Africa S-Amlodipine Sales Market Share by Type (2018-2023)
Figure 65. Middle East & Africa S-Amlodipine Sales Market Share by Application (2018-2023)
Figure 66. Egypt S-Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 67. South Africa S-Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 68. Israel S-Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 69. Turkey S-Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 70. GCC Country S-Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of S-Amlodipine in 2022
Figure 72. Manufacturing Process Analysis of S-Amlodipine
Figure 73. Industry Chain Structure of S-Amlodipine
Figure 74. Channels of Distribution
Figure 75. Global S-Amlodipine Sales Market Forecast by Region (2024-2029)
Figure 76. Global S-Amlodipine Revenue Market Share Forecast by Region (2024-2029)
Figure 77. Global S-Amlodipine Sales Market Share Forecast by Type (2024-2029)
Figure 78. Global S-Amlodipine Revenue Market Share Forecast by Type (2024-2029)
Figure 79. Global S-Amlodipine Sales Market Share Forecast by Application (2024-2029)
Figure 80. Global S-Amlodipine Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of S-Amlodipine
Figure 2. S-Amlodipine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global S-Amlodipine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global S-Amlodipine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. S-Amlodipine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Amlodipine Besylate Tablets
Figure 10. Product Picture of Amlodipine Mesylate Tablets
Figure 11. Product Picture of Amlodipine Maleate Tablets
Figure 12. Global S-Amlodipine Sales Market Share by Type in 2022
Figure 13. Global S-Amlodipine Revenue Market Share by Type (2018-2023)
Figure 14. S-Amlodipine Consumed in Hypertension
Figure 15. Global S-Amlodipine Market: Hypertension (2018-2023) & (K Units)
Figure 16. S-Amlodipine Consumed in Angina pectoris
Figure 17. Global S-Amlodipine Market: Angina pectoris (2018-2023) & (K Units)
Figure 18. Global S-Amlodipine Sales Market Share by Application (2022)
Figure 19. Global S-Amlodipine Revenue Market Share by Application in 2022
Figure 20. S-Amlodipine Sales Market by Company in 2022 (K Units)
Figure 21. Global S-Amlodipine Sales Market Share by Company in 2022
Figure 22. S-Amlodipine Revenue Market by Company in 2022 ($ Million)
Figure 23. Global S-Amlodipine Revenue Market Share by Company in 2022
Figure 24. Global S-Amlodipine Sales Market Share by Geographic Region (2018-2023)
Figure 25. Global S-Amlodipine Revenue Market Share by Geographic Region in 2022
Figure 26. Americas S-Amlodipine Sales 2018-2023 (K Units)
Figure 27. Americas S-Amlodipine Revenue 2018-2023 ($ Millions)
Figure 28. APAC S-Amlodipine Sales 2018-2023 (K Units)
Figure 29. APAC S-Amlodipine Revenue 2018-2023 ($ Millions)
Figure 30. Europe S-Amlodipine Sales 2018-2023 (K Units)
Figure 31. Europe S-Amlodipine Revenue 2018-2023 ($ Millions)
Figure 32. Middle East & Africa S-Amlodipine Sales 2018-2023 (K Units)
Figure 33. Middle East & Africa S-Amlodipine Revenue 2018-2023 ($ Millions)
Figure 34. Americas S-Amlodipine Sales Market Share by Country in 2022
Figure 35. Americas S-Amlodipine Revenue Market Share by Country in 2022
Figure 36. Americas S-Amlodipine Sales Market Share by Type (2018-2023)
Figure 37. Americas S-Amlodipine Sales Market Share by Application (2018-2023)
Figure 38. United States S-Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 39. Canada S-Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Mexico S-Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 41. Brazil S-Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 42. APAC S-Amlodipine Sales Market Share by Region in 2022
Figure 43. APAC S-Amlodipine Revenue Market Share by Regions in 2022
Figure 44. APAC S-Amlodipine Sales Market Share by Type (2018-2023)
Figure 45. APAC S-Amlodipine Sales Market Share by Application (2018-2023)
Figure 46. China S-Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 47. Japan S-Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 48. South Korea S-Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 49. Southeast Asia S-Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 50. India S-Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 51. Australia S-Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 52. China Taiwan S-Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 53. Europe S-Amlodipine Sales Market Share by Country in 2022
Figure 54. Europe S-Amlodipine Revenue Market Share by Country in 2022
Figure 55. Europe S-Amlodipine Sales Market Share by Type (2018-2023)
Figure 56. Europe S-Amlodipine Sales Market Share by Application (2018-2023)
Figure 57. Germany S-Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 58. France S-Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 59. UK S-Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 60. Italy S-Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Russia S-Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 62. Middle East & Africa S-Amlodipine Sales Market Share by Country in 2022
Figure 63. Middle East & Africa S-Amlodipine Revenue Market Share by Country in 2022
Figure 64. Middle East & Africa S-Amlodipine Sales Market Share by Type (2018-2023)
Figure 65. Middle East & Africa S-Amlodipine Sales Market Share by Application (2018-2023)
Figure 66. Egypt S-Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 67. South Africa S-Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 68. Israel S-Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 69. Turkey S-Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 70. GCC Country S-Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of S-Amlodipine in 2022
Figure 72. Manufacturing Process Analysis of S-Amlodipine
Figure 73. Industry Chain Structure of S-Amlodipine
Figure 74. Channels of Distribution
Figure 75. Global S-Amlodipine Sales Market Forecast by Region (2024-2029)
Figure 76. Global S-Amlodipine Revenue Market Share Forecast by Region (2024-2029)
Figure 77. Global S-Amlodipine Sales Market Share Forecast by Type (2024-2029)
Figure 78. Global S-Amlodipine Revenue Market Share Forecast by Type (2024-2029)
Figure 79. Global S-Amlodipine Sales Market Share Forecast by Application (2024-2029)
Figure 80. Global S-Amlodipine Revenue Market Share Forecast by Application (2024-2029)
